Colorectal cancer (CRC) is generally characterized by a high prevalence of Fusobacterium
nucleatum (F. nucleatum), a spindle‐shaped, Gram‐negative anaerobe pathogen derived …

Colorectal cancer (CRC), one of the most common and deadliest diseases worldwide, poses
a great health threat and social burden. The clinical treatments of CRC encompassing …

Immunotherapy of triple-negative breast cancer (TNBC) has an unsatisfactory therapeutic
outcome due to an immunologically “cold” microenvironment. Fusobacterium nucleatum (F …

Sonosensitizers in current sonodynamic therapy (SDT) often suffer from poor delivery
efficiency, phototoxicity, and disputed safety. To overcome these issues, a sonosensitizers …

Sonodynamic therapy (SDT) has demonstrated significant potential in addressing multidrug‐
resistant bacterial infections due to its noninvasive nature and independence from …

In recent years, advancements in microbial sequencing technology have sparked an
increasing interest in the bacteria residing within solid tumors and its distribution and …

Herein, a dual‐sensitizer prodrug, named pro‐THPC, has been designed to function as both
a photosensitizer and a sonosensitizer prodrug for precise antitumor combination therapy …

Many studies suggest that tumor microbiome closely relates to the oncogenesis and anti-
tumor responses in multiple cancer types (eg, colorectal cancer (CRC), breast cancer, lung …

Cancer remains one of the serious threats to human health. The relationship between
bacteria and various tumours has been widely reported in recent years, and studies on intra …

The microbiome has emerged as a significant biomarker and modulator in cancer
development and treatment response. Recent research highlights the notable role of …